Navigation

• Home
• News
• Kiefer summary
• Members
  • wibailis
    • Baldwin Paper
    • PDFs
    • Baldwin Review
    • Research Paper
    • Research Project (gp41) references
      • [···]
      • Overview of the global AIDS epidemic
      • Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41
      • Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
      • Core structure of gp41 from the HIV envelope glycoprotein
      • HIV entry and its inhibition
      • Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity
      • Mechanisms of viral membrane fusion and its inhibition
      • Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region
      • Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
      • The prefusogenic intermediate of HIV-1 gp41 contains exposed C-peptide regions
      • Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion
      • Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs
      • Structural basis for paramyxovirus-mediated membrane fusion
      • The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection
      • Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target
      • Thermodynamics of peptide inhibitor binding to hiv-1 gp41
      • N- and C-domains of HIV-1 gp41: Mutation, structure and functions
      • Inhibiting HIV-1 entry: Discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket
      • HIV-1 inhibition by a peptide [3]
      • Different from the HIV fusion inhibitor C34, the anti-HIV drug fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120
      • The entry of entry inhibitors: A fusion of science and medicine
      • Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41
      • Molecular strategies to inhibit HIV-1 replication
      • Determinants of human immunodeficiency virus types 1 resistance to gp41- derived inhibitory peptides
      • Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
      • Newly identified host factors modulate HIV replication
      • [···]
      • [···]
      • [···]

Log in

Login Name

Password

Cookies are not enabled. You must enable cookies before you can log in.

Forgot your password?